Patrick Campbell

A recent study of more than 50,000 found that antidepressant use could reduce a third of deaths among diabetic patients with depression.

A recent study from Penn Medicine found that just 5% of patients with a mutation of the TTN gene have dilated cardiomyopathy.

Investigators found that weight loss interventions were significantly associated with improvements in biomarkers, including alanine aminotransferase.

A recent study of 775 found that low vitamin D levels at birth were associated with an increased risk of elevated systolic blood pressure in childhood and adolescence.

Recent study finds that positron emission tomography myocardial perfusion imaging can help identify diabetic patients at increased risk of heart attack.

After examining a cohort of 14,599 people, investigators found that meeting minimum physical activity guidelines could prevent 46% of deaths at population level.

A recent study found that initiation of dialysis was associated with a decline in functional status and a rise in caregiver burden.

FDA approval of eculizumab (Soliris) marks the first approval for the treatment of NMOSD.

An analysis of more than 650 eyes find that optical coherence tomography central subfield thickness accounts for only a small proportion of total variation in changes in visual acuity.

A recent analysis of 46 trials found that the total cholesterol and LDL-C lowering effects of soy are consistent over time and back the FDA's 1999 health claim.

A recent study examined the relationship between different types of infection and incidence of stroke.

Eli Lilly Co. and Boehringer Ingelheim Pharmaceuticals Inc. announced that empagliflozin (Jardiance) has received a Fast Track designation from the FDA.

A recent study found that every year of education was equivalent to a 2.5% reduction in risk of heart disease.

A recent study found that an additional 2 hours per day of TV viewing time is linked to a 50% increase in a person's risk of cardiovascular events and death.

Acer Therapeutics Inc. announced on Tuesday they received a CRL from the FDA regarding their NDA from celiprolol (Edsivo).

A recent study found that telerehabilitation was comparable to traditional in-clinic rehabilitation for stroke patients.

Recent analysis of 3 trials found that CERT2 showed comparable and synergistic predictive performance when compared with previously published CVD risk models.

A recent study found that plant-based diets can lead to changes in gut microbiota that correlate with weightloss and fat reduction.

Allergan announced approval of the sBLA for treatment in children from the ages of 2 to 17.

Investigators examined anti-VEGF injections claims data among Medicare Part B beneficiaries from 2012 to 2015 and found that aflibercept injections increased by 69% during that time.

A recent study reviewed operating times of ophthalmic procedures before and after transition to a new EHR system in 2 outpatient departments and an ambulatory surgical center.

Analysis of the SURTAVI clinical trial revealed that TAVR and SAVR are both safe for patients with a CABG history.

Survey of 3000 found that more than half of all respondents wish they knew more about heart failure but just 1 in 5 were likely to speak with their doctor out of fear of diagnosis or cost.

A recent study from investigators at Michigan State University found that vitamin D supplementation was not associated with reduced risk of major cardiovascular events.

Christopher Sorli, MD, vice president of medical affairs at Sanofi, discusses the results of a recent trial examining insulin glargine plus lixisenatide.

After Janssen's submission of an sNDA in March, results of the CREDENCE subgroup analyses were among the most anticipated presentations at ADA 2019.

A study presented at ADA 2019 examined the efficacy of sitagliptin compared with dapagliflozin in t2d patients 65 years old and older.

FDA has announced the approval of liraglutide injections for treatment of type 2 diabetes among pediatric patients.

A 6-month study examining the effects of hepatic-directed prandial insulin in patients with type 1 diabetes mellitus was presented at ADA 2019.

Osama Hamdy, MD, PhD, discusses the impact of a 10-year study observing the impact of lifestyle interventions among diabetes patients in real-world clinical practice.